Arkolith/Insider Trading/CLDI/Form 4

Schoeneck James A

DirectorCalidi Biotherapeutics, Inc. (CLDI) · full profile →Form 4 · filed Jun 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 3, 2024Option exercise(M)375K$0.20$75K964K
Jun 3, 2024Option exercise(M)173K$0.20$35K589K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 3, 2024Option exercise(M)173K——202K
Jun 3, 2024Option exercise(M)173K——173K
Jun 3, 2024Option exercise(M)375K——375K
Jun 3, 2024Grant(A)548K——548K
Jun 3, 2024Option exercise(M)375K——0

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-022745) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML